Skip to main content
CreoSG Co.,Ltd. logo

CreoSG Co.,Ltd. — Investor Relations & Filings

Ticker · 040350 ISIN · KR7040350001 KO Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 353 across all filing types
Latest filing 2026-05-18 Capital/Financing Update
Country KR South Korea
Listing KO 040350

About CreoSG Co.,Ltd.

https://www.creosg.com/

CreoSG Co., Ltd. is a company with two primary business divisions: IT solutions and biotechnology. The IT solutions division specializes in providing services to financial institutions, focusing on the development and implementation of next-generation systems, application development, and IT outsourcing. The biotechnology division is dedicated to the research and development of vaccines. Its main pipeline includes an HIV/AIDS vaccine candidate and a COVID-19 vaccine. The company's vaccine development is based on its proprietary recombinant Vesicular Stomatitis Virus (VSV) vector system, which serves as its core technological platform.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시) (제24회차 CB)
Capital/Financing Update Classification · 85% confidence The document is a voluntary disclosure detailing the results of a securities issuance (a private placement of convertible bonds): issuance amount, board resolution date, payment date, listing status, etc. This is an update on the companys financing activity and changes in its capital structure, matching the Capital/Financing Update category.
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 94% confidence The document is titled “분기보고서” (“Quarterly Report”) covering the period 2026-01-01 to 2026-03-31 and includes detailed financial statements, business overview, MD&A, auditor’s opinion, capital changes, share data, and other substantive financial and operational disclosures. It is clearly the full interim/quarterly report rather than an announcement or summary. Therefore, it should be classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
주권매매거래정지해제 (액면병합 주권 변경상장)
Regulatory Filings Classification · 92% confidence The document is an exchange notice in Korean announcing the lifting of a trading suspension for shares, referencing market rules and effective date. It does not present financial results, governance materials, or a report, but is a regulatory/ compliance announcement. This fits the Regulatory Filings fallback category.
2026-05-11 Korean
주요사항보고서(전환사채권발행결정)
Regulatory Filings
2026-05-08 Korean
전환가액의조정
Regulatory Filings
2026-05-07 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Regulatory Filings
2026-05-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.